Acumen Pharmaceuticals
  • About Us
    • Our Team
    • Careers
    • Ask Acumen
  • Our Science
    • PUBLICATIONS
  • Pipeline
    • ALTITUDE-AD
    • INTERCEPT-AD
  • For Patients
    • Expanded Access Policy
    • Clinical Trials
  • Investors & Media
    • News
    • Events
    • Presentations
    • Corporate Governance
    • Financial Information
    • Stock Information
    • PUBLICATIONS
  • Contact
  • Menu Menu

2021 CTAD Presentation

May 31, 2021/in 2021 2021, CTAD, INTERCEPT-AD, Presentation, Trial Design, TwentyTwentyOne /by Robyn Moxon

2021 CTAD Presentation:

 

Phase 1 trial design for ACU193, a monoclonal antibody that selectively binds soluble Aβ oligomers.

https://acumenpharm.com/wp-content/uploads/Untitled-design-4-1.png 2000 1545 Robyn Moxon http://acumenpharm.com/wp-content/uploads/Acumen_Menu_Logo.png Robyn Moxon2021-05-31 08:10:322024-06-10 13:15:092021 CTAD Presentation

Copyright © 2024, Acumen Pharmaceuticals, Inc. | Privacy Policy | Terms of Service

Scroll to top

We value your privacy

Our website and its partners store and/or access information on your device, such as unique cookie identifiers. We use third party cookies to understand how you and other visitors use our website. Please find more information, including on third parties who use cookies in our website, in our Cookies Policy. By clicking "ACCEPT ALL", you confirm that you have read and are agreeing to the use of all cookies. Clicking “ONLY NECESSARY” cookies will permit only those that are necessary for the function of our site, click to learn more about optional cookies HERE. Please note that if you refuse all cookies, some parts of the website may not be displayed.

Accept AllAccept Only Necessary CookiesRefuse All

Cookie and Privacy Settings



How we use cookies

We use two broad categories of cookies: (1) first party cookies, served directly by us to your computer or mobile device, which we use to recognize your computer or mobile device when it revisits our Sites; and (2) third party cookies, which are served by service providers or business partners on our Sites, and can be used by these parties to recognize your computer or mobile device when it visits other websites. Third party analytics cookies can be used for a variety of purposes, including analytics for site traffic, advertising, and social media features. Essential cookies are those that are used to allow for technical operation of the website platform and features.

Essential Website Cookies

These cookies are necessary to allow the technical operation of our Services (e.g., they enable you to move around on a website and to use its features).

Google Analytics Cookies

These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

If you do not want that we track your visist to our site you can disable tracking in your browser here:

Other external services

We also use different external services like Google Webfonts, Google Maps and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Vimeo and Youtube video embeds:

Privacy Policy

You can read about our cookies and privacy settings in detail on our Privacy Policy Page.

Accept settingsRefuse All